BiomarkersHumans
Mid‐ to Late‐Life Changes in Plasma Biomarkers of Alzheimer's Disease Pathology and Neurodegeneration and Associations with Cortical Thickness: The Atherosclerosis Risk in Communities Study
AAIC 2025 Abstract
Abstract
Background: Plasma biomarkers show promise as a noninvasive method for measuring Alzheimer's disease pathology and neurodegeneration throughout the lifecourse. However, the relationship between longitudinal changes in these biomarkers and late‐life brain morphology in community‐dwelling populations requires further investigation.
The paper
James Russell Pike, Yifei Lu, Keenan A. Walker, Priya Palta
Show 12 more authors
Kevin J. Sullivan, Michael E Griswold, Bharat Thyagarajan, Michelle M Mielke, Pamela L. Lutsey, Timothy M. Hughes, David S. Knopman, A. Richey Sharrett, Thomas H. Mosley, Rebecca F. Gottesman, Clifford R. Jack, Josef Coresh,New York University · University of North Carolina at Chapel Hill
AAIC 2025 Abstract · 8 Jan 2026 · CC BY
Presented at AAIC 2025
